WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com

WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

Big Pharma Provides Lifeline to Chinese Companies Struggling To Survive (Biosp... Out-licensing drugs to MNCs is a natural step for Chinese biotechs, but the recent rise in deals is only scratching at the surface of partnership-ready biotechs in the re...
(8/6/2025)

China Sees Surge in Innovative Drug Approvals ... (8/14/2025)

The Trends Shaping Chinese Pharma Patent Litig... (8/13/2025)

China Biopharma Tracker – July 2025: Funding ... (8/8/2025)

Pharma MNCs in China H1/2025 – Mature Product... (8/8/2025)

Innovation through Talent: How Leadership Is E... (8/7/2025)

Big Pharma Provides Lifeline to Chinese Compan... (8/6/2025)

Novartis Heart Drug A China Case Study: How Dr... (8/6/2025)

What the Latest Volume-Based Procurement Chang... (8/1/2025)

China's Plan to Boost Drug Coverage by Commerc... (7/31/2025)

US Drug Supply Chain Exposure to China (Brooki... (7/29/2025)

Accelerating US Oncology Drug Development Usin... (7/23/2025)

PharmaDJ's China Biopharma Tracker – June 202... (7/22/2025)

CDE Seeks Public Input on Draft Guidelin... (8/14/2025) CDE Issues New Technical Guidelines for ... (8/14/2025) CDE Solicits Comments on Draft ICH M4Q(... (8/14/2025) CDE Seeks Public Input on Draft Guidelin... (8/14/2025) Remegen's Telitacicept Achieves Phase II... (8/14/2025) CTTQ Unveils Promising Phase 2 Data for ... (8/14/2025) YolTech Unveils Breakthru In Vivo Editin... (8/14/2025) GenFleet's GFH375 KRAS G12D Inhibitor De... (8/14/2025) Qihan Earns FDA Green Light for Pioneeri... (8/14/2025) Innovent's U.S. Unit Fortvita Launches P... (8/14/2025) Amphastar Strikes Major Licensing Deal t... (8/14/2025) ArkBio's Ziresovir Included into Pediatr... (8/14/2025) MNCs Target China's New Commercial Insur... (8/13/2025) Summit Skips Quarterly Earnings Call ami... (8/13/2025) Gracell Gains NMPA Approval to Advance G... (8/13/2025) NHSA Publishes Preliminary Review Result... (8/13/2025) CTTQ Secures IND Acceptance from China's... (8/13/2025) Haichang Biotech Completes Nearly CNY 50... (8/13/2025)

China's Innovative Drug Market Surpasses CNY 400 Billio... China's 'Silver Yuan' Set to Power US$134B Boom in Geri... China Hospitals Prioritize Local Innovation, Digital He... China's Pharma Market Faces Mixed Performance in Q1 202... China's Retail Pharmacy Market Hits CNY 941.1B in 2024 ...

Amphastar Strikes Major Licensing Deal to Supercharge P... YolTech Unveils Breakthru In Vivo Editing of Human Bloo... Haichang Biotech Completes Nearly CNY 500M Series C Fin... Summit Skips Quarterly Earnings Call amid Strategic Shi... MNCs Target China's New Commercial Insurance Catalog to...

CDE Seeks Public Input on Draft Guidelines for Rare Dis... CDE Solicits Comments on Draft ICH M4Q(R2) Guidelines ... CDE Issues New Technical Guidelines for Clinical Develo... CDE Seeks Public Input on Draft Guidelines for Bayesian... CDE Seeks Public Comments on Revised Technical Guidelin...

NHSA Publishes Preliminary Review Results for 2025 NRDL... China Launches 11th National VBP Round with New Flexibi... China Urges Price Discipline as Drugmakers Flood Latest... China Issues 2025 Code of Ethics for Medical Profession... China Officially Establishes New Launch Price Mechanism...

U.S. Closes Bribery Investigation into GE Healthcare's ... SAMR Orders Simcere to Reverse Unnotified Merger Over C... U.S. Lawmakers Raise Fresh Alarm Over GenScript's China... Record China Pharma Monopoly Fine Sends Strong Deterren... Conjupro Files USPTO Challenge on Ascletis' U.S. Patent...

India Moves to Set Minimum Import Prices to Protect Pha... China Struggles to Maintain Grip on India's Bulk Drug M... API China 2025 Ends with High Attendance and Global Ind... FDA Issues Warning Letters to Two Chinese API Manufactu... Implications of China's Growing Influence in Global Pha...

ArkBio's Ziresovir Included into Pediatric RSV Drug Pri... Innovent's U.S. Unit Fortvita Launches Phase 1 Trial of... Qihan Earns FDA Green Light for Pioneering Dual-Target ... GenFleet's GFH375 KRAS G12D Inhibitor Delivers Strong N... CTTQ Unveils Promising Phase 2 Data for HER2 Bispecific...

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Recent Executive Moves Recent Official and Executive Moves Recent Official and Executive Moves Recent Executive Moves Astellas Pharma Executive Sentenced to 3½ Years in Chi...

China Introduces Plan for Pudong New Area's Pilot Compr... Upcoming Event: 2023 Pharma CI USA Conference & Exhibit... Upcoming Event: 15th Annual Pharma Market Research Conf... Upcoming Event: 6th International Conference on Emergin... Upcoming Event: PHARM Connect Congress

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

2023 Order Form + Product Descripti... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu...